Skip NavigationSkip to Content

Characterization of the Effects of Aryl-azido Compounds and UVA Irradiation on the Viral Proteins and Infectivity of Human Immunodeficiency Virus Type 1

  1. Author:
    Belanger, J. M.
    Raviv, Y.
    Viard, M.
    de la Cruz, M. J.
    Nagashima, K.
    Blumenthal, R.
  2. Author Address

    [Belanger, Julie M.; Blumenthal, Robert] NCI, Ctr Canc Res Nanobiol Program, Frederick, MD 21701 USA. [Raviv, Yossef; Viard, Mathias] NCI, Basic Res Program, SAIC Frederick, Frederick, MD 21701 USA. [de la Cruz, Michael Jason; Nagashima, Kunio] NCI, Adv Technol Program, SAIC Frederick, Frederick, MD 21701 USA.;Blumenthal, R, NCI, Ctr Canc Res Nanobiol Program, Frederick, MD 21701 USA.;blumenthalr@mail.nih.gov
    1. Year: 2010
    2. Date: Sep-Oct
  1. Journal: Photochemistry and Photobiology
    1. 86
    2. 5
    3. Pages: 1099-1108
  2. Type of Article: Article
  3. ISSN: 0031-8655
  1. Abstract:

    Hydrophobic UV-activatable compounds have been shown to partition into the hydrophobic region of biological membranes to selectively label transmembrane proteins, and to inactivate enveloped viruses. Here, we analyze various UV-activatable azido- and iodo-based hydrophobic compounds for their ability to inactivate a model-enveloped virus, human immunodeficiency virus (HIV-1 MN). Treatment of HIV-1 with 1,5-diazidonapthalene (DAN), 1-iodo, 5-azidonaphthalene (INA), 1-azidonaphthalene (AzNAP) or 4,4'-diazidobiphenyl (DABIPH) followed by UVA irradiation for 2 min resulted in complete viral inactivation, whereas treatment using analogous non-azido-containing controls had no effect. Incorporation of an azido moiety within these hydrophobic compounds to promote photoinduced covalent reactions with proteins was found to be the primary mechanism of viral inactivation for this class of compounds. Prolonged UVA irradiation of the virus in the presence of these azido compounds resulted in further modifications of viral proteins, due to the generation of reactive oxygen species, leading to aggregation as visualized via Western blot analysis, providing additional viral modifications that may inhibit viral infectivity. Furthermore, inactivation using these compounds resulted in the preservation of surface antigenic structures (recognized by neutralizing antibodies b12, 2g12 and 4e10), which is favorable for the creation of vaccines from these inactivated virus preparations.

    See More

External Sources

  1. DOI: 10.1111/j.1751-1097.2010.00780.x
  2. WOS: 000281638700017

Library Notes

  1. Fiscal Year: FY2009-2010
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel